Skip to main content
. 2018 Feb 21;5(3):275–283. doi: 10.1002/ehf2.12258

Table 4.

Dosing of heart failure therapy before initiation of sacubitril/valsartan

Variable Total population (n = 120)
ACE‐I, % of target dose 59 ± 29
ARB, % of target dose 49 ± 29
Beta‐blocker, % of target dose 54 ± 25
Spironolactone, mg 25 (25–25)
Loop diuretic, mg furosemide equivalents 40 (20–40)

ACE‐I, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker.